Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Merck & Co. Inc.: The Transformation of a 130-Year-Old Pharmaceutical Leader Focusing on Cancer Treatment

05 Jan, 2026

3 Pharmaceutical Stocks to Purchase at a Bargain Price | The Motley Fool

27 Dec, 2025

3 Pharmaceutical Stocks to Purchase at a Reduced Price - The Globe and Mail

27 Dec, 2025

How Will the New Pricing Agreement with the Government Affect BMY's Sales?

23 Dec, 2025

See More